Strategic wins included a global automotive leader selecting Palo Alto Networks for a $50 million deal and a global technology supplier for over $40 million, both driven by platformization and ...
ZS trades at a forward P/E of 45, compressing to 30 by FY 2028, but market fears over share losses demand outperformance in RPO and retention. Read why ZS is a Hold.
Napoleon's Bryce Schneider takes down Delacs-Burlington's Breyden Buee at 152-pounds on Thursday, Feb. 19, 2026, during the North Dakota Class B individual state wrestling tournament semifinals at the ...
Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...
NeoGenomics, Inc. (NASDAQ:NEO) Q4 2025 Earnings Call Transcript February 17, 2026 NeoGenomics, Inc. misses on earnings ...
Detailed price information for Natural Gas Services Group (NGS-N) from The Globe and Mail including charting and trades.
2d
Is CareDx (CDNA) Quietly Redefining Its Moat With AlloHeme’s Early Relapse Detection Breakthrough?
In February 2026, CareDx, Inc. reported pivotal clinical validation data for AlloHeme, an AI-powered, NGS-based blood test ...
Creative Biolabs is accelerating gene therapy research globally with specialized expertise. SHIRLEY, NY, UNITED STATES, ...
What is the Market Size of Precision Medicine Research and Development Platform? The global market for Precision Medicine ...
A rare but serious clotting disorder linked to certain COVID-19 vaccines and natural adenovirus infections has puzzled ...
On this episode of GEN Live, we deliver a full debrief on the news from AGBT—critical to understanding where NGS, spatial, single-cell, and multiomics are headed.
GeneDx Holdings: recent performance and business profile GeneDx Holdings (WGS) has been on many investors’ radars after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results